For the estimated 20% of Western adults living with chronic gastroesophageal reflux disease, medication dependency is a daily reality — yet a growing body of procedural options now offers durable alternatives. Understanding which intervention fits which patient profile has become one of gastroenterology's more nuanced clinical decisions, and this JAMA Insights piece helps clarify the landscape considerably.
The review examines the mechanistic rationale and clinical evidence behind five distinct intervention categories: radiofrequency energy delivery to the lower esophageal sphincter (the Stretta procedure), transoral incisionless fundoplication (TIF), endoscopic full-thickness plication, mucosal resection, and ablation-based techniques. Each approach targets the anatomical or functional defect responsible for reflux — typically a weakened or misdirected lower esophageal sphincter — through different tissue-remodeling pathways. The piece evaluates outcomes including symptomatic relief, proton pump inhibitor discontinuation rates, and procedural safety profiles, offering clinicians a structured comparison rather than isolated trial data.
This synthesis arrives at a moment when long-term PPI safety concerns — including associations with kidney disease, dementia risk, and microbiome disruption — are prompting patients and physicians alike to reconsider indefinite pharmacological suppression. Radiofrequency ablation and TIF have the most accumulated evidence, with several randomized trials and meta-analyses supporting meaningful symptom reduction and reduced medication dependence, though neither rivals laparoscopic Nissen fundoplication in durability for severe cases. Endoscopic plication techniques remain more heterogeneous in their evidence base, with smaller trials and variable follow-up periods limiting definitive conclusions. A key limitation across this entire procedural category is patient selection: hiatal hernia size, Barrett's esophagus status, and esophageal motility all modulate outcomes substantially. For health-conscious adults managing mild-to-moderate GERD, this review is an important signal that non-surgical endoscopic options are maturing — though shared decision-making with a gastroenterologist remains essential before any medication discontinuation.